Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 26,38126,400 of 606,025 grants

Active RESEARCH GRANT GBP
Improved vaccine production by engineering the agroinfiltration platform
Biotechnology and Biological Sciences Research Cou... University of Oxford United Kingdom 2024 – 2027

This proposal aims to revolutionize vaccine production in plants. Vaccines can be quickly and efficiently produced in plants through agroinfiltration of Nicotiana benthamiana to pr...

£6.82M
GBP
Active RESEARCH GRANT GBP
Improved vaccine production by engineering the agroinfiltration platform
Biotechnology and Biological Sciences Research Cou... John Innes Centre United Kingdom 2024 – 2027

Abstracts are not currently available in GtR for all funded research.This is normally because the abstract was not required at the time of proposal submission, but may be because i...

£626.7K
GBP
Active NON-SBIR/STTR RPGS
Developing, Implementing and Supporting NCI Clinical Trials and the National Cancer Trials Network (NCTN) in Breast Cancer and Developmental Therapeutics- A 5 Year Plan
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

Project Summary/Abstract Dr. Ciara O’Sullivan is a medical oncologist focusing on clinical and translational research in breast cancer (BC) and developmental therapeutics. Her rese...

$1.77M
USD
Active NON-SBIR/STTR RPGS
Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Project Summary/Abstract Gynecologic Cancer remains an underfunded area of research with funding to lethality scores significantly lower than other cancer sites. Endometrial cancer...

$1.32M
USD
Active NON-SBIR/STTR RPGS
An Innovative Digitally-Delivered Olfactory Method for Reducing Cigarette Cravings and Supporting Smoking Cessation
NATIONAL CANCER INSTITUTE University of Houston United States 2024 – 2027

ABSTRACT Cigarette smoking is the leading cause of preventable death and disability in the United States. Smoking cessation rates have stagnated in recent years, underscoring the n...

$2.8M
USD
Active NON-SBIR/STTR RPGS
Pediatric toxoplasmosis: Addressing unmet medical need with 3D printed dose flexible delivery systems of pyrimethamine, sulphadiazine and leucovorin
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... Texas A&M University Health Science Ctr United States 2024 – 2029

ABSTRACT / PROJECT SUMMARY Toxoplasmosis is a life-threatening food-borne/congenital disease that can have severe implications in immuno-compromised children. The US Center for Dis...

$5.81M
USD
Active NON-SBIR/STTR RPGS
A Pilot Feasibility HIV prevention Study Linking Incarcerated Women to Post-Release Pre-exposure prophylaxis (PrEP) Services
NATIONAL INSTITUTE OF MENTAL HEALTH University of North Carolina Chapel Hill United States 2024 – 2027

ABSTRACT This application proposes to adapt a Formerly Incarcerated Transitions (FIT) program for mostly African American women, often with health disparities, who are released fro...

$6.78M
USD
Active NON-SBIR/STTR RPGS
Targeting GTP Cyclohydrolase 1 for treating chronic orofacial pain
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... University of Florida United States 2024 – 2026

PROJECT SUMMARY Chronic pain is a global healthcare problem that reduces the quality of patients’ lives and increases med- ical expenditures. Inadequate pain control with available...

$4.19M
USD
Active NON-SBIR/STTR RPGS
Effect of the plantar skin microenvironment on tumor metastasis and drug tolerance
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary Patients with advanced acral melanoma (AM) suffer worse outcomes relative to patients with cutaneous melanoma (CM), in part, because they do not respond as well to...

$4.26M
USD
Active NON-SBIR/STTR RPGS
Impact of seizure onset pattern on temporal lobe seizure propagation through the basal ganglia
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... Emory University United States 2024 – 2029

SUMMARY The objective of this proposal is to investigate how temporal lobe (TL) seizures with different onset patterns propagate through the basal ganglia (BG) and to evaluate the...

$6.74M
USD
Active OTHER RESEARCH-RELATED
Modeling the Impact of Interventions to Reduce Typhoidal Salmonella Transmission in the Indo-Pacific.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Stanford University United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT The typhoidal Salmonellas (TS), primarily Salmonella Typhi and Paratyphi A, are a major cause of global morbidity and mortality, particularly in Asia whe...

$1.69M
USD
Active NON-SBIR/STTR RPGS
Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

SUMMARY. The Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVAMPP Center will utilize both well-defined and novel approac...

$441.09M
USD
Active NON-SBIR/STTR RPGS
Core A: Administrative Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT – Core A: Administrative Core The Administrative Core A of the Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVA...

Active NON-SBIR/STTR RPGS
Core B: Data Management Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core B: Data Management Core Washington University (Miller, J. Philip) The overarching objective of the Data Management Core-B is to serve as the central hub for the analy...

Active NON-SBIR/STTR RPGS
Core C: Structure Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

PROJECT SUMMARY - Core C: Structure Core Structure-based vaccine antigen design is a key component of the prototype pathogen approach to pandemic preparedness. For each prototype p...

Active NON-SBIR/STTR RPGS
Core D: Antibody Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core D: Antibody Core Washington University (Ellebedy, Ali) Respiroviruses, Rubulaviruses, Peribunyaviruses, and Phenuiviruses present major health burdens and have pandem...

Active NON-SBIR/STTR RPGS
Core E: Immunogenicity and Immune Correlates Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core E: Immunogenicity and Immune Correlates Core (Correlates) The goal of Core E-Correlates will be to provide support to the projects by conducting various technical mea...

Active NON-SBIR/STTR RPGS
Prototype strategies for antibodies and vaccines for respiroviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

Human parainfluenza virus type 3 (HPIV3) is the P1-Respiroviruses prototype for advancement of vaccines and therapeutic antibodies against respiroviruses due to the advanced state...

Active NON-SBIR/STTR RPGS
Prototype strategy for vaccines and antibodies to rubulaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

Project 2: Abstract Rubulaviruses are respiratory pathogens with a high level of transmissibility (R0 = 4-7). MuV is an ideal prototype pathogen to study paramyxoviruses because we...

Active NON-SBIR/STTR RPGS
Prototype strategy for vaccines and antibodies to Peribunyaviridae
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

SUMMARY. The long term goals of Project 3 of the Respiro, Rubula, Peribunya, Phenui (R2P2) ReVAMPP are to use a prototype pathogen approach to identify and validate generalizable v...